Validation of a Questionnaire Assessing Quality of Life in Children With Amblyopia and Strabismus

The validation of a French questionnaire is very important to assess rigorously and objectively the impact of the treatments of strabismus and amblyopia on children quality of life.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Amblyopia Brain Diseases Central Nervous System Diseases Cranial Nerve Diseases Eye Diseases Nervous System Diseases Neurologic Manifestations Ocular Motility Disorders Pathological Conditions, Signs and Symptoms Sensation Disorders Signs and Symptoms Strabismus Vision Disorders

Age range

3 year–17 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Fondation Ophtalmologique Adolphe de Rothschild

Paris, 75019, France

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

children with a status of strabismus or not strabismus made by a specialized ophthalmologist
children with a status of amblyopia or not amblyopia made by a specialized ophthalmologist
signed consent of parents

Exclusion criteria

ocular pathology (except for isolated ametropia)
evolutive paralytic strabismus
antecedent of surgery for strabismus
strabismus surgery in the past 6 months
disease with possible impact on the child's answers, such as severe neurologic troubles)
poor knowledge of French language

Treatment and study plan

Primary outcomes

validation of the questionnaire

Time frame: immediate

Sponsors and collaborators

Lead sponsor

Fondation Ophtalmologique Adolphe de Rothschild

Network

Registry information

Acronym: ASTEQ

Important dates

Primary completion: 2015
First posted: Aug 26, 2016
Registry last updated: Aug 26, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed